Lindbrook Capital »

Aquestive Therapeutics shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Aquestive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aquestive Therapeutics held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aquestive Therapeutics by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $543 109 4.98

More positions owned by Lindbrook Capital

Vanguard Total Stk Mkt Etf (VTI)
Vanguard Total Intl Stock Idex Etf Etf (VXUS)
Apple Stock (AAPL)
Spdr S&p 500 Etf Trust Etf (SPY)
Golub Cap Bdc Cef (GBDC)
Ishares Russell 1000 Growth Etf Etf (IWF)
Nvidia Corporation Stock (NVDA)
Microsoft Stock (MSFT)
Rpar Risk Parity Etf Etf (RPAR)
Amazon.com Stock (AMZN)
Broadcom Stock (AVGO)
Ishares Russell 1000 Value Etf Etf (IWD)
Powershares Qqq Tr Etf (QQQ)
Google Stock (GOOGL)
Vanguard Growth Etf Etf (VUG)

View all positions for Lindbrook Capital

Top funds holding Aquestive Therapeutics

Bratton Capital Management
BlackRock
Vanguard Group
VR Adviser
Franklin Resources
Geode Capital Management
MPM Oncology Impact Management
State Street Corporation
Blue Owl Capital Holdings
Janney Montgomery Scott
Goldman Sachs Group
Morgan Stanley
Bank of America Corporation
Essex Investment Management
Northern Trust

View all funds holding Aquestive Therapeutics